How has been the historical performance of Cravatex?

Answer:The historical performance of Cravatex shows significant fluctuations in key financial metrics over the years.

Breakdown:
Cravatex's net sales have seen a sharp decline from 594.33 Cr in March 2022 to 173.76 Cr in March 2025, reflecting a downward trend in total operating income, which dropped from 778.67 Cr in March 2020 to the same 173.76 Cr in March 2025. The total expenditure has also decreased, from 534.00 Cr in March 2023 to 175.45 Cr in March 2025, indicating a reduction in operational costs. Despite these reductions, the operating profit (PBDIT) has remained negative since March 2023, with a slight recovery to 8.26 Cr in March 2025. The profit before tax has fluctuated, reaching 6.37 Cr in March 2025, while the profit after tax has stabilized at 4.83 Cr for both March 2025 and March 2024. The company's net profit margin has shown a decline from 11.7% in March 2023 to 2.78% in March 2025. On the balance sheet, total liabilities decreased from 364.59 Cr in March 2022 to 140.70 Cr in March 2025, while total assets also declined from 364.59 Cr to 140.70 Cr in the same period. Cash flow from operating activities has seen a significant drop from 143.00 Cr in March 2023 to 2.00 Cr in March 2025, indicating challenges in generating cash from core operations. Overall, Cravatex's financial performance reflects a challenging environment with declining revenues and profitability, alongside a significant reduction in liabilities.